We describe the telemedicine experience of an Italian ALS tertiary Center during COVID-19 pandemic. A total of 144 visits were scheduled between 6th March and 6th April 2020. These mostly consisted of neurological or psychological visits (139, 96.5%). One hundred thirty-nine (96.5%) visits were performed as telemedicine and mostly via phone call (112, 80.6%). Three (2.1%) visits were considered as urgent and maintained as outpatient care. Additionally, patients were still able to telephone, being put through directly to their neurologists. Many requests of contact were addressed at getting information about the scheduled visits or examinations (45, 43.3%). Globally, patients and caregivers were satisfied with the telemedicine service. However, the majority (85, 65.9%) would prefer a face-to-face visit. In conclusion, telemedicine could be considered a good complement to face-to-face care, even after social restrictions have been eased.

Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience / Vasta, R.; Moglia, C.; D'Ovidio, F.; Di Pede, F.; De Mattei, F.; Cabras, S.; Peotta, L.; Iazzolino, B.; Giusiano, S.; Manera, U.; Palumbo, F.; Bombaci, A.; Torrieri, M. C.; Ilardi, A.; Mastro, E.; Arcari, M.; Solero, L.; Grassano, M.; Daviddi, M.; Matteoni, E.; Salamone, P.; Fuda, G.; Canosa, A.; Chio, A.; Calvo, A.. - In: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. - ISSN 2167-8421. - 22:3-4(2021), pp. 308-311. [10.1080/21678421.2020.1820043]

Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience

Bombaci A.;
2021-01-01

Abstract

We describe the telemedicine experience of an Italian ALS tertiary Center during COVID-19 pandemic. A total of 144 visits were scheduled between 6th March and 6th April 2020. These mostly consisted of neurological or psychological visits (139, 96.5%). One hundred thirty-nine (96.5%) visits were performed as telemedicine and mostly via phone call (112, 80.6%). Three (2.1%) visits were considered as urgent and maintained as outpatient care. Additionally, patients were still able to telephone, being put through directly to their neurologists. Many requests of contact were addressed at getting information about the scheduled visits or examinations (45, 43.3%). Globally, patients and caregivers were satisfied with the telemedicine service. However, the majority (85, 65.9%) would prefer a face-to-face visit. In conclusion, telemedicine could be considered a good complement to face-to-face care, even after social restrictions have been eased.
2021
Inglese
Taylor and Francis Ltd.
22
3-4
308
311
4
Pubblicato
https://www.tandfonline.com/doi/full/10.1080/21678421.2020.1820043
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
Amyotrophic lateral sclerosis
COVID-19
motor neuron diseases
remote consultation
telemedicine
No
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience / Vasta, R.; Moglia, C.; D'Ovidio, F.; Di Pede, F.; De Mattei, F.; Cabras, S.; Peotta, L.; Iazzolino, B.; Giusiano, S.; Manera, U.; Palumbo, F.; Bombaci, A.; Torrieri, M. C.; Ilardi, A.; Mastro, E.; Arcari, M.; Solero, L.; Grassano, M.; Daviddi, M.; Matteoni, E.; Salamone, P.; Fuda, G.; Canosa, A.; Chio, A.; Calvo, A.. - In: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. - ISSN 2167-8421. - 22:3-4(2021), pp. 308-311. [10.1080/21678421.2020.1820043]
none
25
info:eu-repo/semantics/article
262
Vasta, R.; Moglia, C.; D'Ovidio, F.; Di Pede, F.; De Mattei, F.; Cabras, S.; Peotta, L.; Iazzolino, B.; Giusiano, S.; Manera, U.; Palumbo, F.; Bombaci...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/159129
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
social impact